We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck, about staffing clinical trial operations as part of our new interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
We wanted to share this excerpt from the conversation with Adam:
When you are working on the
ArcheMedX is heading west January 12th-15th for the 38th Annual JP Morgan Healthcare Conference. Let's connect in San Francisco to explore how behavioral science and actionable insights can improve clinical trial readiness and commercial success.
Please contact our team to coordinate a specific time to meet during the conference and /
When sponsors and contract research organizations (CROs) make decisions about which sites to include in a clinical trial, they too often rely on outdated historical data and show little confidence in the additional data the sites provide to them.
For example, when completing the traditional site feasibility assessment sites may guess
The principal investigator (PI) meeting is a well-established (and expensive) tradition in the pharmaceutical industry. And, in our era of global programs, you might need to host multiple PI meetings: one for the Americas, one in Europe, one in Asia. Yet, no matter how many meetings you host, you will
One of the best analogies on learning that I ever learned came in a rather unlikely place.
I had just walked from my car to meet a PGA Top 100 golf instructor (John Dunigan), he was going to help me work through some issues with my game. 15 minutes into the
I recently had the pleasure to spend time with the team at Applied Clinical Trials. Following our discussion they published an interview in the September edition of Applied Clinical Trials Magazine.
The interview is titled "Workforce Readiness Technology Minimizes Risk in Clinical Trials" and it explores how ArcheMedX is enabling Sponsors,
Ready, our operational intelligence and workforce readiness platform, received a very warm welcome from the clinical trials industry at the DIA 2019 Global Annual Meeting.
During the Meeting, I was invited to join PharmaVoice to discuss how Ready analyzes behavioral data to enable Sponsors, CROs, and other trial stakeholders to evaluate
ArcheMedX was recently featured in Pharmaforum
June 7, 2019 - By Richard Staines
ArcheMedx, which provides tech solutions for life sciences and healthcare, has launched a new digital service that aims to cut risks and costs associated with under-performing clinical trials.
The company will unveil the tool called Ready at this year’s Drug
I am thrilled to announce the launch of Ready, our new operational intelligence and workforce readiness platform for the clinical trials industry. This is an exciting time for the ArcheMedX team, and we would like to thank all those who have supported our growth and evolution.
Ready enables clinical operations leaders to
evaluate and improve
Charlottesville, VA, June 6, 2019 – ArcheMedX, the premier provider of operational intelligence and workforce readiness solutions for the life sciences and healthcare industries, is pleased to announce the launch of Ready, a new digital platform to reduce the risks and costs associated with underperforming clinical trials, at this year’s